Neuroscience Archives - Page 5 of 13

How Do Bipolar Disorder Type I & Type II Differ?

Article February 10, 2020

Traditionally, bipolar disorder type II (BDII) has been thought to be less severe—and less disabling—than bipolar disorder type I (BDI). Experts believe this characterization might be attributed to the fact… Read More

Foundations & Future Plans For Precision Medicine In The Treatment Of GAD

Article February 10, 2020

Generalized anxiety disorder (GAD) is a broad disorder marked by uncontrollable worry that affects daily life for at least six months. It is considered a chronic condition and is marked… Read More

Technology & Mental Health: Defining The Current Landscape

On-Demand Webinar November 19, 2019

In 2018, approximately 43% of patients with mental illness received clinical treatment.1 Technological advances in mental health are expanding access to consumers. During this webinar, Drs. Megan Coder and Jake… Read More

Proposed Roles Of Modulating Norepinephrine In Psychiatric Illnesses

Video September 9, 2019

Dr. Gwen Morris examines the relationship between norepinephrine and psychiatric illnesses. She first investigates an overlap between monoaminergic pathways and circuitry. Then, she demonstrates how malfunctioning cortical circuits can influence… Read More

An Update On Pharmacogenetics Testing In Psychiatry With Dr. Joseph Goldberg

Interview August 19, 2019

Listen in as Dr. Joseph Goldberg discusses pharmacogenetics testing in the field of psychiatry and how it is evolving from the bench to the bedside. Dr. Goldberg reviews the pros… Read More

Follow Up Q&A With Dr. Rowland – The Role Of Glutamate In Mood Disorders & Schizophrenia

Interview August 5, 2019

During this question and answer session, Dr. Laura Rowland responds to unanswered questions from the PsychU webinar, “The Role of Glutamate in Mood Disorders & Schizophrenia,” which took place on… Read More

Follow Up Q&A With Dr. Murrough – The Role Of Glutamate In Mood Disorders & Schizophrenia

Interview July 29, 2019

During this question and answer session, Dr. James Murrough responds to unanswered questions from the PsychU webinar, “The Role of Glutamate in Mood Disorders & Schizophrenia,” which took place on… Read More

PsychU Supporters: An Interview With The Center For Emotional Fitness

Interview July 23, 2019

Listen in as Dr. Leon Rosenberg introduces you to the work of the Center For Emotional Fitness (CFEF) – a PsychU Supporting Organization. Dr. Rosenberg shares a brief overview of… Read More

Cognitive Function & Neuroprotection In Schizophrenia

On-Demand Webinar June 26, 2019

Schizophrenia has a worldwide prevalence of approximately 1%.1 Individuals living with the disease often experience neurocognitive deficits, as well as poor memory and attention, which are considered core symptoms for… Read More

The Neurobiology Of Endocannabinoids

Video June 17, 2019

Hear from Chloe Liu, Ph.D., a Medical Science Liaison with Otsuka Pharmaceutical Development & Commercialization, Inc., as she examines the historical research discoveries and underlying neurobiological mechanisms of the endocannabinoid… Read More

Now Leaving PsychU

This link will take you outside of the PsychU community website

PsychU

Sorry, this content is no longer available.

Stay Connected: